New insights into Chlamydia and arthritis. Promise of a cure?

Annals of the Rheumatic Diseases

Volumn 73, Issue 4, 2014, Pages 637-644

  Zeidler, Henning ^a   Hudson, Alan P ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZAPROPAZONE; AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; ETANERCEPT; GLUCOCORTICOID; INDOMETACIN; INFLIXIMAB; KETOPROFEN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RIFAMPICIN; SALAZOSULFAPYRIDINE; TETRACYCLINE DERIVATIVE;

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DRUG EFFICACY; HUMAN; MORBIDITY; NOMENCLATURE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSIOTHERAPY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REINFECTION; REITER SYNDROME; REVIEW; SPONDYLARTHRITIS;

INFECTIONS; REACTIVE ARTHRITIS; SPONDYLOARTHRITIS; TREATMENT;

ANTI-BACTERIAL AGENTS; ARTHRITIS, REACTIVE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; SPONDYLARTHRITIS; TERMINOLOGY AS TOPIC;

EID: 84895423090     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204110     Document Type: Review

References (104)

1. Zeidler H, Kuipers J, Köhler L. Chlamydia-induced arthritis. Curr Opin Rheumatol 2004;16:380-92. (Pubitemid 38803139)
2. Carter JD, Hudson AP. The evolving story of Chlamydia-induced reactive arthritis. Curr Opin Rheumatol 2010;22:424-30.
3. Gérard HC, Whittum-Hudson JA, Carter JD, et al. The pathogenic role of Chlamydia in spondyloarthritis. Curr Opin Rheumatol 2010;22:363-7.
4. Owlia MB, Eley AR. Is the role of Chlamydia trachomatis underestimated in patients with suspected reactive arthritis? Int J Rheum Dis 2010;13:27-38.
5. Carter JD, Inman RD. Chlamydia-induced reactive arthritis: hidden in plain sight? Best Pract Res Clin Rheumatol 2011;25:359-74.
6. Carter JD, Espinoza LR, Inman RD, et al. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum 2010;62:1298-307.
7. Rihl M, Kuipers JG, Köhler L, et al. Combination antibiotics for Chlamydia-induced arthritis: breakthrough to a cure? Arthritis Rheum 2010;62:1203-7.
8. Zeidler HK, Schumacher HR. Chlamydia-induced arthritis. In: Calin A, Taurog JD. eds. The Spondyloarthritides. Oxford, New York, Tokyo: Oxford University Press, 1998:69-96.
9. Zeidler H, Calin A, Amor B. A historical perspective of the spondyloarthritis. Curr Opin Rheumatol 2011;23:327-33.
10. Hannu T, Inman R, Granfors K, et al. Reactive arthritis or post-infectious arthritis? Best Pract Res Clin Rheumatol 2006;20:419-33. (Pubitemid 43843064)
11. Morris D, Inman RD. Reactive Arthritis: Developments and Challenges in Diagnosis and Treatment. Curr Rheumatol Rep 2012;14:390-4.
12. Wollenhaupt HJ, Schneider C, Zeidler H, et al. Clinical and serological characterization of Chlamydia-induced arthritis. Dtsch Med Wochenschr 1989;114:1949-54. (Pubitemid 20011181)
13. Lauhio A, Leirisalo-Repo M, Lähdevirta J, et al. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991;34:6-14.
14. Silveira LH, Gutiérrez F, Scopelitis E, et al. Chlamydia-induced reactive arthritis. Rheum Dis Clin North Am 1993;19:351-62. (Pubitemid 23170204)
15. Bas S, Cunningham T, Kvien TK, et al. The value of isotype determination of serum antibodies against Chlamydia for the diagnosis of Chlamydia reactive arthritis. Br J Rheumatol 1996;35:542-7.
16. Bas S, Cunningham T, Kvien TK, et al. Synovial fluid and serum antibodies against Chlamydia in different forms of arthritis: intra-articular IgA production in Chlamydia sexually acquired reactive arthritis. Br J Rheumatol 1996;35:548-52.
17. Gérard HC, Wang GF, Balin BJ, et al. Frequency of apolipoprotein E (APOE) allele types in patients with Chlamydia-associated arthritis and other arthritides. Microb Pathog 1999;26:35-43. (Pubitemid 29084378)
18. Schumacher HR Jr. Chlamydia-associated reactive arthritis. Isr Med Assoc J 2000;2:532-5.
19. Appel H, Kuon W, Kuhne M, et al. Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis. Arthritis Res Ther 2004;6:R521-34.
20. Ozgül A, Dede I, Taskaynatan MA, et al. Clinical presentations of chlamydial and non-chlamydial reactive arthritis. Rheumatol Int 2006;26:879-85. (Pubitemid 43962116)
21. Moling O, Pegoretti S, Rielli M, et al. Chlamydia pneumoniae-reactive arthritis and persistent infection. Br J Rheumatol 1996;35:1189-90. (Pubitemid 26397626)
22. Bas S, Vischer TL. Humoral immunity in Chlamydia trachomatis arthritis. Rev Rhum Engl Ed 1999;66(1 Suppl):34S-5S.
23. Bas S, Muzzin P, Fulpius T, et al. Indirect evidence of intra-articular immunoglobulin G synthesis in patients with Chlamydia trachomatis reactive arthritis. Rheumatology (Oxford) 2001;40:801-5.
24. Nikkari S, Puolakkainen M, Närvänen A, et al. Use of a peptide based enzyme immunoassay in diagnosis of Chlamydia trachomatis triggered reactive arthritis. J Rheumatol 2001;28:2487-93. (Pubitemid 33031981)
25. Ardeniz O, Gülbahar O, Mete N, et al. Chlamydia pneumoniae arthritis in a patient with common variable immunodeficiency. Ann Allergy Asthma Immunol 2005;94:504-8. (Pubitemid 40547940)
26. Harrer T, Bäuerle M, Bergmann S, et al. Inhibition of HIV-1-specific T-cells and increase of viral load during immunosuppressive treatment in an HIV-1 infected patient with Chlamydia trachomatis induced arthritis. J Clin Virol 2005;34:224-30. (Pubitemid 41427320)
27. Savolainen E, Kettunen A, Närvänen A, et al. Prevalence of antibodies against Chlamydia trachomatis and incidence of C. trachomatis-induced reactive arthritis in an early arthritis series in Finland in 2000. Scand J Rheumatol 2009;38:353-6.
28. Baeten D, Breban M, Lories R, et al. Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? Arthritis Rheum 2013;65:12-20.
29. Zeidler H. The historical concept of interrelated conditions lumped together as a family of distinct diseases is not outdated. Arthritis Rheum 2013;65:2214-5.
30. Rich E, Hook EW 3rd, Alarcon GS, et al. Reactive arthritis in patients attending an urban sexually transmitted disease clinic. Arthritis Rheum 1996;39:1172-7. (Pubitemid 26240231)
31. Kvien TK, Glennås A, Melby K, et al. Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatol 1994;21:115-22. (Pubitemid 24044930)
32. Savolainen E, Kaipiainen-Seppänen O, Kröger L, et al. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol 2003;30:2460-8. (Pubitemid 37413909)
33. Wollenhaupt J, Kolbus F, Weissbrodt H, et al. Manifestations of Chlamydia induced arthritis in patients with silent versus symptomatic urogenital chlamydial infection. Clin Exp Rheumatol 1995;13:453-8.
34. Fendler C, Laitko S, Sörensen H, et al. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis 2001;60:337-43. (Pubitemid 32242745)
35. Weyand CM, Goronzy JJ. Clinically silent infections in patients with oligoarthritis: results of a prospective study. Ann Rheum Dis 1992;51:253-8.
36. Schnarr S, Putschky N, Jendro MC, et al. Chlamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis: results of a prospective study. Arthritis Rheum 2001;44:2679-85. (Pubitemid 33049345)
37. Burillo A, Bouza EP. Chlamydophila pneumoniae. Infect Dis Clin North Am 2010;24:61-71.
38. Blasi F, Tarsia P, Aliberti S. Chlamydophila pneumoniae. Clin Microbiol Infect 2009;15:29-35.
39. Melby KK, Kvien TK, Glennås A, et al. Chlamydia pneumoniae as a trigger of reactive arthritis. Scand J Infect Dis 1999;31:327-8. (Pubitemid 29389250)
40. Hannu T, Puolakkainen M, Leirisalo-Repo M. Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology (Oxford) 1999;38:411-14. (Pubitemid 29507124)
41. Schumacher HR, Gérard HC, Arassi TK, et al. Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients. Arthritis Rheum 1999;42:1889-93. (Pubitemid 30257753)
42. Carter JD, Gérard HC, Espinoza LR, et al. Chlamydiae as etiologic agents in chronic undifferentiated spondyloarthritis. Arthritis Rheum 2009;60:1311-16.
43. Charles W, Stratton MD. Association of Chlamydia pneumoniae with chronic human diseases. Antimicrobics Diseases Newsletter 2000;18:49-55.
44. Swanborg RH, Boros DL, Whittum-Hudson JA, et al. Molecular mimicry and horror autotoxicus: do chlamydial infections elicit autoimmunity? Expert Rev Mol Med 2006;8:1-23. (Pubitemid 44848624)
45. Rihl M, Köhler L, Klos A, et al. Persistent infection of Chlamydia in reactive arthritis. Ann Rheum Dis 2006;65:281-4. (Pubitemid 43268213)
46. Carter JD, Inman RD, Whittum-Hudson J, et al. Chlamydia and chronic arthritis. Ann Med 2012;44:784-92.
47. Carter JD, Gerard HC, Whittum-Hudson JA, et al. The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis. Int J Clin Rheumtol 2012;7:627-40.
48. Köhler L, Nettelnbreker E, Hudson AP, et al. Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes. Microb Pathog 1997;22:133-42. (Pubitemid 27160259)
49. Gérard HC, Köhler L, Branigan PJ, et al. Viability and gene expression in Chlamydia trachomatis during persistent infection of cultured human monocytes. Med Microbiol Immunol 1998;187:115-20. (Pubitemid 28495518)
50. Kuipers JG, Zeidler H, Köhler L. How does Chlamydia cause arthritis? Rheum Dis Clin North Am 2003;29:613-29. (Pubitemid 36993544)
51. Gérard HC, Whittum-Hudson JA, Carter JD, et al. Molecular biology of infectious agents in chronic arthritis. Rheum Dis Clin North Am 2009;35:1-19.
52. Rusconi B, Greub G. Chlamydiales and the innate immune response: friend or foe? FEMS Immunol Med Microbiol 2011;61:231-44.
53. Choroszy-Król IC, Frej-Ma̧drzak M, Jama-Kmiecik A, et al. Characteristics of the Chlamydia trachomatis species-immunopathology and infections. Adv Clin Exp Med 2012;21:799-808.
54. Hu VH, Holland MJ, Burton MJ. Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis. PLoS Negl Trop Dis 2013;2:e2020.
55. Gérard HC, Stanich JA, Whittum-Hudson JA, et al. Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue. Microb Pathog 2010;48:62-8.
56. Haller-Schober EM, El-Shabrawi Y. Chlamydial conjunctivitis (in adults), uveitis, and reactive arthritis, including SARA. Sexually acquired reactive arthritis. Best Pract Res Clin Obstet Gynaecol 2002;16:815-28. (Pubitemid 41123378)
57. Munoz Rodríguez FJ, Antonio Rebollo MT, Miret Mas C, et al. Chlamydia trachomatis pneumonia in the adult. Med Clin (Barc) 1996;107:796-7.
58. Samra Z, Pik A, Guidetti-Sharon A, et al. Severe Chlamydia trachomatis pneumonia in a patient with no immune deficiency. Arch Intern Med 1988;148:1345-6.
59. Paran H, Heimer D, Sarov I. Serological, clinical and radiological findings in adults with bronchopulmonary infections caused by Chlamydia trachomatis. Isr J Med Sci 1986;22:823-7. (Pubitemid 17017216)
60. Tack KJ, Peterson PK, Rasp FL, et al. Isolation of Chlamydia trachomatis from the lower respiratory tract of adults. Lancet 1980;1:116-20. (Pubitemid 10193046)
61. Quint KD, Bom RJ, Quint WG, et al. Anal infections with concomitant Chlamydia trachomatis genotypes among men who have sex with men in Amsterdam, the Netherlands. BMC Infect Dis 2011;11:63.
62. Li JH, Cai YM, Yin YP, et al. Prevalence of anorectal Chlamydia trachomatis infection and its genotype distribution among men who have sex with men in Shenzhen, China. Jpn J Infect Dis 2011;64:143-6.
63. Manavi K. A review on infection with Chlamydia trachomatis. Best Pract Res Clin Obstet Gynaecol 2006;20:941-51. (Pubitemid 44824841)
64. Miyashita N, Niki Y, Nakajima M, et al. Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest 2001;119:1416-19. (Pubitemid 32686023)
65. Yli-Kerttula UJ, Vilppulla AH. Reactive salpingitis. In: Toivanen A, Toivanen P. eds. Reactive arthritis. Boca. Raton, FL: CRC Press, 1988:125-31.
66. Rizzo A, Domenico MD, Carratelli CR, et al. The role of Chlamydia and Chlamydophila infections in reactive arthritis. Intern Med 2012;51:113-17.
67. Gérard HC, Carter JD, Hudson AP. Chlamydia trachomatis is present and metabolically active during the remitting phase in synovial tissues from patients with chronic Chlamydia-induced reactive arthritis. Am J Med Sci 2013;346:22-5.
68. Kobayashi S, Tamura N, Ichikawa G, et al. Infection related arthritis induced by tonsillar Chlamydia trachomatis and Streptococcal infection. Clin Exp Rheumatol 2002;5:732. (Pubitemid 35243792)
69. Zeidler H. Reactive arthritis and Reiter's syndrome. In: Dieppe P, Wollheim FA, Schumacher HR. eds. Classic Papers in Rheumatology. London: Martin Dunitz Ltd, 2002:148-55.
70. Panush RS, Wallace DJ, Dorff RE, et al. Retraction of the suggestion to use the term "Reiter's syndrome" sixty-five years later: the legacy of Reiter, a war criminal, should not be eponymic honor but rather condemnation. Arthritis Rheum 2007;56:693-4.
71. Braun J, Kingsley G, Van Der Heijde D, et al. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999. J Rheumatol 2000;27:2185-92.
72. Freise J, Bernau I, Meier S, et al. Detection of Chlamydia trachomatis-DNA in synovial fluid: evaluation of the sensitivity of different DNA extraction methods and amplification systems. Arthritis Res Ther 2009;11:R175.
73. Freise J, Gérard HC, Bunke T, et al. Optimised sample DNA preparation for detection of Chlamydia trachomatis in synovial tissue by polymerase chain reaction and ligase chain reaction. Ann Rheum Dis 2001;60:140-5. (Pubitemid 32102205)
74. Sieper J, Rudwaleit M, Braun J, et al. Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 2002;46:319-27. (Pubitemid 34136569)
75. Rihl M, Wagner AD, Bakhsh KA, et al. Detection of chlamydial DNA in the inflamed sacroiliac joint of a patient with multiple infections. J Clin Rheumatol 2009;15:195-7.
76. Carter JD, Gérard HC, Hudson AP. Psoriasiform lesions induced by tumour necrosis factor antagonists: a skin-deep medical conundrum. Ann Rheum Dis 2008;67:1181-3.
77. Pando J, Yarboro C. Prevalence of Chlamydia trachomatis by PCR in the synovium of patients with early rheumatoid arthritis. Arthritis Rheum 1995;38:S286 (abstract).
78. Rahman M, Cheema AM, Schumacher HR. Molecular evidence for the presence of Chlamydia in the synovium of patients with Reiter's syndrome. Arthritis Rheum 1992;35:521-9.
79. Bas S, Griffais R, Kvien TK, et al. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum 1995;38:1005-13.
80. Schumacher HR, Arayssi T, Branigan P, et al. PCR study for bacterial DNA in normal synovium. Arthritis Rheum 1997;40:S265 (abstract).
81. Olmez N, Wang GF, Li Y, et al. Chlamydial nucleic acids in synovium in osteoarthritis: what are the implications? J Rheumatol 2001;28:1874-80. (Pubitemid 32726938)
82. Kuipers JG, Sibilia J, Bas S, et al. Reactive and undifferentiated arthritis in North Africa: use of PCR for detection of Chlamydia trachomatis. Clin Rheumatol 2009;28:11-6.
83. Contini C, Grilli A, Badia L, et al. Detection of Chlamydophila pneumoniae in patients with arthritis: significance and diagnostic value. Rheumatol Int 2011;31:1307-13.
84. Wollenhaupt J, Schnarr S, Kuipers JG. Bacterial antigens in reactive arthritis and spondarthritis. Rational use of laboratory testing in diagnosis and follow-up. Baillière's Clin Rheumatol 1998;12:627-47. (Pubitemid 28558478)
85. Geisler WM. Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis 2011;53 (Suppl 3):S92-8.
86. Bas S, Vischer TL. Chlamydia trachomatis antibody detection and diagnosis of reactive arthritis. Br J Rheumatol 1998;37:1054-9.
87. Bas S, Genevay S, Schenkel MC, et al. Importance of species-specific antigens in the serodiagnosis of Chlamydia trachomatis reactive arthritis. Rheumatology (Oxford) 2002;41:1017-20.
88. Rihl M, Klos A, Köhler L, et al. Infection and musculoskeletal conditions: Reactive arthritis. Best Pract Res Clin Rheumatol 2006;20:1119-37.
89. Feng XG, Xu XJ, Ye S, et al. Recent Chlamydia pneumoniae infection is highly associated with active ankylosing spondylitis in a Chinese cohort. Scand J Rheumatol 2011;40:289-91.
90. Ni AP, Lin GY, Yang L, et al. A seroepidemiologic study of Chlamydia pneumoniae, Chlamydia trachomatis and Chlamydia psittaci in different populations on the mainland of China. Scand J Infect Dis 1996;28:553-7. (Pubitemid 27092392)
91. Bellido-Casado J, Martín-Escudero JC, Tasende-Mata J, et al. Chlamydophila pneumoniae seroprevalence in adults from the general population. Med Clin (Barc) 2006;126:765-7.
92. Bébéar C, De Barbeyrac B. Genital Chlamydia trachomatis infections. Clin Microbiol Infect 2009;15:4-10.
93. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2010. Chlamydial infections. http://www.cdc.gov/std/ treatment/2010/chlamydial-infections.htm (access 16 Feb. 2013).
94. Wang Y, Kahane S, Cutcliffe LT, et al. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathogens 2011;7:e1002258.
95. Nguyen BD, Valdivia RH. Virulence determinants in the obligate intracellular pathogen Chlamydia trachomatis revealed by forward genetic approaches. Proc Natl Acad Sci (USA) 2012;109:1263-8.
96. Gérard HC, Mishra MK, Mao G, et al. Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Nanomedicine 2013;9:996-1008.
97. Hannu T. Reactive arthritis. Best Pract Res Clin Rheumatol 2011;25:347-57.
98. Barber CE, Kim J, Inman RD, et al. Antibiotics for treatment of reactive arthritis: a systematic review and metaanalysis. J Rheumatol 2013;40:916-28.
99. Carter JD, Valeriano J, Vasey FB. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J Rheumatol 2004;31:1973-80. (Pubitemid 39336722)
100. Egsmose C, Hansen TM, Andersen LS, et al. Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial. Ann Rheum Dis 1997;56:32-6. (Pubitemid 27060570)
101. Clegg DO, Reda DJ, Weisman MH, et al. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996;39:2021-7.
102. Schafranski MD. Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection. Rheumatol Int 2010;30:679-80.
103. Edrees A. Successful use of etanercept for the treatment of Reiter's syndrome: a case report and review of the literature. Rheumatol Int 2012;32:1-3.
104. Meyer A, Chatelus E, Wendling D, et al. Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis. Arthritis Rheum 2011;63:1274-80.